|
Following are excerpts from vol. 2 no.1 of The Vaccine Reaction, a
publication of The National Vaccine Information Center
MICROBIOLOGIST ISSUES A CHALLENGE TO SCIENCE
DID THE FIRST ORAL POLIO VACCINE LOTS CONTAMINATED WITH MONKEY
VIRUSES CREATE A MONKEY-HUMAN HYBRID CALLED HIV-1?
At the Eighth Annual Houston Conference on AIDS in America, Howard B. Urnovitz, Ph.D.,
a microbiologist, founder and chief science officer of Calypte Biomedical in Berkeley,
California challenged medical science to prove wrong his theory that the human
immunodeficiency virus Type-1(HlV-1) is a monkey-human hybrid that was created after more
than 320,000 Africans were injected between 1957 and 1959 with lots of experimental live
oral polio vaccines contaminated with different monkey viruses. The vaccines, said
Urnovitz, may have contained live simian immunodeficiency virus (SIV) or they were present
environmentally as an opportunistic infection. The central core of his theory of the
origins of HIV-1 rests on the thesis that, in a certain number of African vaccine
recipients, SIV recombined with their own normal genes to create a monkey-human hybrid now
known as HIV-1. Simultaneously he forwarded the theory that early "inactivated"
Salk vaccines given to some 98 million Americans were also contaminated with monkey
viruses and may be one reason why there has been an explosion of cancer, new infectious
agents and other new immune and neurological disorders among the baby boomers born between
1941 and 1961.
Epidemic Diseases Linked To Early Polio Vaccines
Although Dr. Urnovitz pointed to early experimental live oral polio vaccine trials in
the Congo as the possible origin of HIV-1, the infection which can in some individuals
lead to the deadly AIDS (acquired immune deficiency syndrome), he also pointed to
inactivated Salk vaccine lots contaminated with monkey viruses and given to children in
the U.S. between 1955 and 1961 as possibly having set this generation up for immune and
neurological disorders after they were exposed to opportunistic infections and
environmental toxins as adults. He pointed to the sudden emergence of Human T-Cell
Leukemia, epidemic Kaposi's sarcoma, Burkitt's Lymphoma, herpes (HHV-6, HHV-7, HHV-8),
Epstein-Barr, cytomegalovirus, and chronic fatigue syndrome and other disorders following
early polio vaccine campaigns in the U.S. and around the world.
Building his case step by step and supporting it with evidence from 30 years of
published literature as well as original research data, Urnovitz made his compelling
argument to AIDS patients, physicians and medical researchers at the Houston AIDS
conference, arguing that the proof his theory is highly plausible lies in the high tech
world of microbiology not in the more speculative world of epidemiology.
What's In a Name?
Urnovitz pointed out that endogenous retroviruses (ERVs), which are also called
retrotransposons or "jumping genes," are normal genes found in rodents, cows,
birds, and monkeys and, after the polio vaccine campaigns of the 1950's and 1960's, were
identified in humans in the early 1980's. One of the key characteristics of jumping genes
is that they can easily recombine with fragments of other viruses, both human and animal,
and form new hybrid viruses called chimeras. This, maintains Urnovitz, is what he believes
happened after monkey viruses were introduced into humans in Africa via experimental live
oral polio vaccines: the simian immunodeficiency virus (SIV), which is identical in
genetic structure to HIV-2, came into contact with a human endogenous retrovirus (HERV)
that had an HIV-1 envelope and the two viruses swapped envelopes to produce a genetic
hybrid that causes the HIV-1 infection that can lead to full blown AIDS (acquired immune
deficiency syndrome) and death.
The complete volume of the Vaccine Reaction this is excerpted from is
available from The National Vaccine Information Center. Call for subscription info at
703-938-0342, or visit their web-site at http://www.909shot.com/
Chronic Illnet Research microbiologist Dr.
Howard B. Urnovitz's site covers many topics, including Vaccine Safety and Chronic Diseases.
|
|
